Design and synthesis of peptide conjugates of phosphoramide (cas 13597-72-3) mustard as prodrugs activated by prostate-specific antigen

Add time:09/01/2019    Source:sciencedirect.com

A series of Glutaryl-Hyp-Ala-Ser-Chg-Gln-4-aminobenzyl phosphoramide (cas 13597-72-3) mustard conjugates (1a–e) was designed and synthesized as potential prodrugs for site-specific activation by PSA in prostate cancer cells. All conjugates were found to be substrates of PSA with cleavage occurring between Gln and the para-aminobenzyl (PAB) linker. Structure–activity relationship studies on these conjugates indicated that introduction of electron-withdrawing fluorine(s) on the phenyl ring in the PAB linker uniformly improved the chemical stability of the conjugates while the position of substitution affected differently the self-immolative process of conjugates upon proteolysis. Introduction of a fluorine at ortho position to benzylic phosphoramide as in 1b results in better stability of the conjugate prior to activation while maintaining its antiproliferative activity upon activation by PSA. The conjugate 1b with 2-fluoro substitution was identified as a promising lead for further evaluation and optimization in the development of prostate cancer-targeted prodrugs.

We also recommend Trading Suppliers and Manufacturers of phosphoramide (cas 13597-72-3). Pls Click Website Link as below: cas 13597-72-3 suppliers

Prev:Synthesis and structure–activity relationships of nitrobenzyl phosphoramide (cas 13597-72-3) mustards as nitroreductase-activated prodrugs
Next:Hirshfeld surface analysis of new organotin(IV)-phosphoramide (cas 13597-72-3) complexes)